Blueprint Medicines Corporation (BPMC)
Blueprint Medicines Corporation (BPMC)
$97.75 USD
0.49 (-0.50%)
Updated Jul 19 12:00am
Add BPMC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
BPMC Daily Price Range
BPMC 52-Week Price Range
BPMC News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesBlueprint Medicines Corporation (BPMC) Company Bio
Blueprint Medicines Corporation makes kinase drugs to treat patients with genomically defined diseases. The company was founded in 2008 and is based in Cambridge, Massachusetts.
BPMC Stock Chart More Charts
BPMC Price/Volume Stats
| Current price | $97.75 |
| Prev. close | $98.24 |
| Day low | $97.00 |
| Day high | $101.91 |
| 50-day MA | $88.42 |
| 200-day MA | $74.06 |
| 52-week high | $101.91 |
| 52-week low | $44.58 |
| Volume | 436,400 |
| Avg. volume | 461,104 |
| Dividend yield | N/A |
| Market Cap | 4.78B |
BPMC Returns
| 1-mo | 2.71% |
| 3-mo | 29.59% |
| 6-mo | 46.64% |
| 1-year | 56.93% |
| 3-year | 356.99% |
| 5-year | N/A |
| YTD | 81.32% |
| 2018 | -28.51% |
| 2017 | 168.84% |
| 2016 | 6.49% |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...